Tripping over parents: barriers to access to pharmaceuticalmedicines in the developing world and proposed solutions to enhance access within the WTO framework

Thesis / Dissertation

2007

Permanent link to this Item
Authors
Supervisors
Journal Title
Link to Journal
Journal ISSN
Volume Title
Publisher
Publisher

University of Cape Town

License
Series
Abstract
Four years after which members of the World Trade Organisation ("WTO") agreed upon a system by which developing countries could import generic versions of patented medicines produced without authorisation of patent holders to address public health needs, no country had yet spoken. 1 On July 19, 2007, Rwanda took a dramatic leap of faith to break the spell of silence and become the first and only country to inform the WTO of its intent to utilise those very procedures. Before Rwanda, no developing country had ever made use of compulsory licensing as a tool to address public health issues.
Description

Reference:

Collections